the role of interferon in the treatment of accelerated/blast phase mpn
Published 1 month ago • 124 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:50
criteria for the diagnosis of accelerated/blast phase mpn and challenges clinicians may face
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:18
phase i/ii tg01 study exploring the use of vaccination in ras-mutated myeloma
-
1:32
blast-phase mpns: a major unmet need in the field
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
16:42
management of treatment-naïve lr-mds
-
10:34
remission induction therapy prior to allosct in aml: insights from the asap trial
-
17:12
jun hua: differential laminar activation dissociates encoding and retrieval in entorhinal cortex
-
15:45
updates on the use of ropeginterferon in the treatment of mpns
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:36
the use of outpatient cilta-cel in the treatment of multiple myeloma
-
3:07
the impact of blast enumeration & co-occurring myelodysplasia-related mutations in npm1-mutated aml
-
1:14
the potential of uproleselan in patients with aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:42
the future of cll treatment: aiming for long-lasting remission
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds